Making Long-Acting Injectables Work In Clinical Practice – Strategic & Operational Considerations: A Discussion with Greg Ganse, Chief Executive Officer of Altruix

Greg Ganse, Chief Executive Officer, Altruix, & Monica E. Oss, Chief Executive Officer, OPEN MINDS, discuss the strategic and operational considerations for implementing long-acting injectables (LAIs) in behavioral health settings, and what it takes to turn clinical intent into scalable action.

In this session, Greg Ganse, CEO of Altruix, joins OPEN MINDS CEO Monica Oss to explore the infrastructure, workflows, and staffing strategies behavioral health organizations need to successfully deliver long-acting injectables.

Together, Greg and Monica explore how provider organizations can overcome operational barriers, staffing shortages, and administrative hurdles to expand access to LAIs.

Greg Ganse, Chief Executive . . .